Newer β-Lactam/β-Lactamase Inhibitor for Multidrug-Resistant Gram-Negative Infections: Challenges, Implications and Surveillance Strategy for India-Reference-Cited by-同舟云学术

Newer β-Lactam/β-Lactamase Inhibitor for Multidrug-Resistant Gram-Negative Infections: Challenges, Implications and Surveillance Strategy for India

Published:2018-07 Issue:3 Volume:36 Page:334-343
ISSN:0255-0857
Container-title:Indian Journal of Medical Microbiology
language:en
Short-container-title:Indian Journal of Medical Microbiology

Author:

Veeraraghavan Balaji,Pragasam Agila Kumari,Bakthavatchalam Yamuna Devi,Anandan Shalini,Ramasubramanian V,Swaminathan Subramanian,Gopalakrishnan Ram,Soman Rajeev,Abraham OC,Ohri Vinod C,Walia Kamini

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference67 articles.

1. Overcoming resistance to β-lactam antibiotics;Worthington;J Org Chem,2013

2. B-lactamases: A Focus on current challenges;Bonomo;Cold Spring Harb Perspect Med,2017

3. Extended spectrum beta-lactamases: A mini review of clinical relevant groups;Sullivan;J Med Microbiol Diagn,2015

4. The growing genetic and functional diversity of extended spectrum beta-lactamases;Ur Rahman;Biomed Res Int,2018

5. Mobile genetic elements associated with antimicrobial resistance;Partridge;Clin Microbiol Rev,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial susceptibility pattern of newer beta lactam-beta lactamase inhibitor agents on the carbapenem resistant and sensitive strains of Enterobacterales and Pseudomonas aeruginosa;IP International Journal of Medical Microbiology and Tropical Diseases;2024-06-15

2. A novel strategy of infusion of ceftazidime-avibactam plus aztreonam for the treatment of infections due to OXA48 & NDM producing carbapenem resistantKlebsiella pneumoniae: Time is of the essence;2024-03-22

3. Effectiveness of Ceftazidime-Avibactam in Gram-Negative Nosocomial Pneumonia: A Real-World Study in India;Cureus;2024-02-19

4. Profile of Cutaneous Bacterial Flora in Pemphigus Patients;Journal of Laboratory Physicians;2023-05-05

5. Prevalence of multidrug-resistant strains in device associated nosocomial infection and their in vitro killing by nanocomposites;Annals of Medicine & Surgery;2022-06